Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 27 Jan 2026. The item focuses on Pediatric-Friendly Formulations: Critical to Maximizing Benefit of Novel Therapeutics Such as Selumetinib for Children With Neurofibromatosis and Other Neoplasms. Review the original article for the full source wording and details.
Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 27 Jan 2026.
The item focuses on Pediatric-Friendly Formulations: Critical to Maximizing Benefit of Novel Therapeutics Such as Selumetinib for Children With Neurofibromatosis and Other Neoplasms.
Review the original article for the full source wording and details.